RE: Any possible share price targetsI believe share appreciation will continue until phase IIa results come out in March, all indications are they will be positive, when confirmed watch out!
I picked up a small amount of shares in Biochem Pharma at $1.00 as on of my very first investments (3TC treatment for AIDS), at the time it was QSSP eligible at something like 50%, after accounting for several splits and prior to their takeout the same share was worth something like $400. Suffice it to say that I haven't ever seen a small cap bio investment with the same type of potential until I discovered SSS. A long way to go to get to that type of valuation, but I believe the potential is there, provided we don't get taken out by a major player first.